查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
印度生命科学工具市场评估：依类型、依技术、依产品、依最终用户、依地区、机会、预测，2017-2031 年
市场调查报告书
商品编码
1400718

印度生命科学工具市场评估：依类型、依技术、依产品、依最终用户、依地区、机会、预测，2017-2031 年

India Life Science Tools Market Assessment, By Type, By Technology, By Product, By End-user, By Region, Opportunities and Forecast, FY2017-FY2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 153 Pages | 商品交期: 3-5个工作天内

价格

2023年印度生命科学工具市场规模为144.4亿美元。预计到 2031 年，市场规模将达到 337.6 亿美元，2024 年至 2031 年的预测期间复合年增长率为 11.22%。

由于各种因素，印度生命科学工具市场正在经历显着的成长和创新。随着医疗保健领域的快速扩张和对研发的日益重视，对先进工具和技术的需求正在迅速增加。由于印度政府采取了各种旨在促进仪器、消耗品和设备本地製造的举措，生命科学产业正在经历巨大的成长。值得注意的措施包括 "Make in India" 活动和 "National Medical Device Policy 2023" 。此外，生物技术和医疗器材园区的建立以及对研究机构的资助增加吸引了投资并培育了该行业的创新文化。这些政府主导的措施在推动市场向前发展方面发挥着重要作用。基因组研究及其在医疗保健领域的应用，包括基因检测、生物标记发现和精准医学，在印度正在迅速成长。这推动了尖端生命科学工具的采用，包括下一代定序 (NGS) 平台、基因分型阵列和生物资讯解决方案。印度的製药和生物技术产业也为生命科学工具市场的成长做出了贡献。印度是全球药品製造中心，对药物发现、开发和品质控制工具和技术的需求也不断增加。

该报告研究了印度生命科学工具市场，并提供了市场概况，包括依类型、技术、产品、最终用户、地区和参与市场的公司概况划分的趋势。

目录

第一章研究方法论

第二章 专案范围与定义

第三章 COVID-19 对印度生命科学工具市场的影响

第 4 章执行摘要

第五章印度生命科学工具市场展望，2017-2031

  • 市场规模及预测
  • 依类型
  • 依技术
  • 依产品
  • 依最终用户
  • 依地区
  • 依公司划分的市占率 (%)，2023 年

第 6 章 市场测绘，2023 年

第七章 宏观环境与产业结构

  • 供需分析
  • 进出口分析-数量与价值
  • 供应/价值链分析
  • PESTEL 分析
  • 波特五力分析

第八章市场动态

第九章 监理架构与创新

第十章 主要与企业状况

第11章价格分析

第十二章案例研究

第十三章 主要进入者展望

  • Becton Dickinson India Private Limited
  • Agilent Technologies India Private Limited
  • Illumina Inc.
  • Thermo Fisher Scientific Inc.
  • Roche Products India Private Limited
  • Bio-Rad Laboratories India Private Limited
  • Merck Life Science Private Limited
  • Wipro GE Healthcare Private Limited
  • Bruker India Scientific Private Limited
  • Qiagen India Private Limited

第十四章 战略建议

第十五章 查询及免责声明

Product Code: MX10160

India Life Science Tools Market size was valued at USD 14.44 billion in FY2023 which is expected to reach USD 33.76 billion in FY2031 with a CAGR of 11.22% for the forecast period between FY2024 and FY2031. The life sciences tools market in India is experiencing significant growth and innovation driven by various factors. With a rapidly expanding healthcare sector and a growing focus on research and development, the demand for advanced tools and technologies is increasing rapidly. The life sciences sector is experiencing a significant boost due to various government initiatives that aim to promote local manufacturing of instruments, consumables and devices in India. Some of the notable initiatives are "Make in India" campaign and the "National Medical Device Policy 2023." Additionally, the establishment of biotechnology and medical device parks, along with increasing funding for research institutions, has attracted investments and fostered a culture of innovation within the sector. These government-led efforts are playing a vital role in driving the market forward. India is witnessing a surge in genomics research and its application in healthcare, including genetic testing, biomarker discovery, and precision medicine. This has led to the adoption of cutting-edge life sciences tools such as next-generation sequencing (NGS) platforms, genotyping arrays, and bioinformatics solutions. The pharmaceutical and biotechnology industry in India is also contributing to the growth of the life sciences tools market. With India being a global hub for pharmaceutical manufacturing, the demand for tools and technologies for drug discovery, development, and quality control is also increasing.

Rising Prevalence of Genetic Disorders and Targeted Infectious Disease

The increasing incidence of genetic disorders and the need for precise tools to combat infectious disease have become pivotal drivers in propelling the growth of the life sciences tools market in India. As advancements in genomics and diagnostics continue to unfold, there is an increasing demand for sophisticated tools that facilitate genetic research, diagnosis, and targeted therapies. The incidence of tuberculosis in India is 210 per 100,000 population. India stands at 36th position globally in terms of incidence rates. More than 330,000 people died due to Tuberculosis in 2022. About 2.4 million are living with HIV in India. The three Southern States with the highest percentage of people living with HIV are Maharashtra, Andhra Pradesh, and Karnataka.

Technological Advancements in Genomics and Personalized Medicine

India life science tools market is witnessing significant advancements in genomics and personalized medicine, which are revolutionizing the field of life sciences tools. The rapid progress in genomics research and the availability of cost-effective sequencing technologies have enabled large-scale genomic studies and personalized medicine initiatives. The integration of genomics into healthcare is driving the demand for advanced life sciences tools that are facilitating genetic testing, biomarker discovery, and the development of targeted therapies tailored to individual patients. Additionally, the emergence of data analytics, artificial intelligence (AI), and machine learning (ML) in genomics and personalized medicine is opening new possibilities for data interpretation, predictive modeling, and precision medicine applications. These advancements in genomics and personalized medicine are poised to transform healthcare delivery and offer innovative solutions for diagnosing, treating, and managing various diseases in the Indian population.

In April 2023, a Gurgaon-based PredOmix, a cancer screening startup, developed a new blood test with 98% accuracy rate for identifying 32 distinct cancers in both men and women. The company's patent technology OncoVeryx-F uses artificial intelligence (AI) and metabolomics, or the study of tiny molecules, to find metabolite signatures of several malignancies in a single test.

Biopharmaceutical Companies are Dominating the Market Among End-Users

Biopharmaceutical companies accounted for 27.86% of India life science tools market. India has emerged as a global hub for biopharmaceutical and pharmaceutical manufacturing, with a strong presence in generic drug and life sciences tools production. The biotechnology sector is also expanding rapidly, with increasing investments in research and development, biopharmaceutical manufacturing, and clinical trials. Indian companies are investing in state-of-the-art equipment such as high-performance liquid chromatography (HPLC) systems, mass spectrometers, sequencing platforms, and molecular biology tools to enhance their capabilities and meet the industry's evolving requirements. Additionally, the sector's focus on innovative drug development, biologics, and biosimilars is further driving the demand for specialized tools and technologies in areas such as genetic engineering, protein analysis, and cell culture systems. The growing revenues of biopharmaceutical companies in India presents significant opportunities for the life sciences tools market, fostering innovation, research collaborations, and technological advancements.

Genomix, a genetic testing company, made its debut in India in 2022, introducing its comprehensive range of genetic testing services. The company provides an array of tests that encompass various aspects of genetics, such as assessing cancer predisposition, carrier status for genetic conditions, and pharmacogenetics testing.

South India Dominates the India Life Science Tools Market

South India emerged as the most dominant region in India life science tools market, showcasing a significant influence in the sector's growth and development. This regional prominence can be attributed to several factors, one of which is the presence of numerous medical device parks in states like Tamil Nadu, Telangana, Kerala and Karnataka. These parks serve as focal points for research, innovation and manufacturing of life sciences tools, creating a conducive environment for the industry to flourish. The strategic positioning these states, combined with proactive government initiatives and a robust ecosystem of research institutions, has propelled South India to the forefront of life sciences tools market in India.

Government Initiatives

The Indian government has introduced a range of initiatives. These include the renowned "Make in India" campaign, which serves to attract investments and encourage innovation. Furthermore, the establishment of biotechnology parks and research institutions across the country has been undertaken to create an environment conducive to the growth of the life science tools market. These initiatives collectively aim to promote the development of cutting-edge technologies, foster R&D, and facilitate a thriving ecosystem for the life sciences industry in India. In May 2023, the cabinet announced the National Medical Device Policy 2023. The aim of this policy is to support a well-organized expansion of the medical device industry in order to fulfill public health goals related to accessibility, affordability, quality, and innovation. The National Medical Device Policy 2023 will held this sector to achieve its maximum capabilities by implementing strategies such as establishing a supportive environment for manufacturing and emphasizing innovation. Additionally, the policy aims to establish a strong and efficient regulatory framework to ensure smooth operations. The government has established 9 biotech parks in Tamil Nadu, Telangana, Kerala, Karnataka, Uttar Pradesh, and Haryana. The Department of Biotechnology (DBT), which operates under the Ministry of Science and Technology, has set up biotechnology parks and incubators throughout the country with the aim of transforming research into viable products and services. These facilities offer essential infrastructure support to facilitate this process.

Impact of COVID-19

India life science tools market experienced a favorable impact due to the COVID-19 pandemic. The outbreak of the virus resulted in a higher prevalence of diseases, leading to a subsequent rise in research and development activities. A notable instance is Cipla's announcement in May 2022, regarding the commercialization of its COVID-19 PCR kit in India. The real-time RT-PCR test kit had undergone validation by a center approved by the Indian Council of Medical Research (ICMR). Separation technologies, such as immunoprecipitation, chromatographic techniques, automated purification systems, and others, play a crucial role in the diagnosis and treatment of COVID-19. For instance, a study published in the Indian Journal of Medical Research in 2021 examined the use of a rapid immunoassay-based chromatographic test for COVID-19 diagnosis in a tertiary care teaching hospital in northern India. The study's findings demonstrated that these immunoassay-based rapid chromatographic tests can contribute to the swift detection, isolation, and treatment of individuals affected by COVID-19.

Key Players Landscape and Outlook

The life science tool market in India is dominated by several key players who are actively contributing to the industry's landscape. These companies offer a wide range of tools, technologies, and services to support research, diagnostics, and other applications in the life sciences sector. Several important participants are implementing strategic measures such as introducing new products, expanding facilities, forming partnerships, and engaging in mergers and acquisitions.

In January 2022, Mylab Discovery Solutions Pvt. Ltd. introduced CoviSwift, a point-of-care testing solution for COVID-19. This development increased the testing capacity in India from 300 laboratories to 60,000 laboratories. CoviSwift as a point-of-care (POC) solution allowed small labs and collection centers to do gold standard RT-PCR testing for COVID-19.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Impact of COVID-19 on the India Life Science Tools Market

4. Executive Summary

5. India Life Science Tools Market Outlook, FY2017-FY2031F

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
    • 5.1.2. By Volume
  • 5.2. By Type
    • 5.2.1. Instruments
    • 5.2.2. Consumables
    • 5.2.3. Services
  • 5.3. By Technology
    • 5.3.1. Genomics
    • 5.3.2. Proteomics
    • 5.3.3. Cell Biology Technology
    • 5.3.4. Lab Supplies
    • 5.3.5. Others
  • 5.4. By Product
    • 5.4.1. Cell Culture Systems & 3D Cell Culture
    • 5.4.2. Liquid Chromatography
    • 5.4.3. Mass Spectrometry
    • 5.4.4. Flow Cytometry
    • 5.4.5. Cloning & Genome Engineering
    • 5.4.6. Microscopy
    • 5.4.7. Next Generation Sequencing
    • 5.4.8. PCR & qPCR
    • 5.4.9. Nucleic Acid Preparation
    • 5.4.10. Nucleic Acid Microarray
    • 5.4.11. Sanger Sequencing
    • 5.4.12. Transfection Devices & Gene Delivery Technologies
    • 5.4.13. Nuclear Magnetic Resonance (NMR)
    • 5.4.14. Others
  • 5.5. By End-user
    • 5.5.1. Healthcare
      • 5.5.1.1. Hospitals
      • 5.5.1.2. Clinics
      • 5.5.1.3. Research Laboratories
      • 5.5.1.4. Diagnostic Laboratories
      • 5.5.1.5. Physician Office
      • 5.5.1.6. Community Centres
    • 5.5.2. Government & Academic Institutions
    • 5.5.3. Biopharmaceutical Company
    • 5.5.4. Industrial Applications
    • 5.5.5. Others
  • 5.6. By Region
    • 5.6.1. North
    • 5.6.2. South
    • 5.6.3. East
    • 5.6.4. West and Central
  • 5.7. By Company Market Share (%), FY2023

6. Market Mapping, FY2023

  • 6.1. By Type
  • 6.2. By Technology
  • 6.3. By End-user
  • 6.4. By Product
  • 6.5. By Region

7. Macro Environment and Industry Structure

  • 7.1. Supply Demand Analysis
  • 7.2. Import Export Analysis - Volume and Value
  • 7.3. Supply/Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat from New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges, Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Clinical Trials
  • 9.2. Patent Landscape
  • 9.3. Regulatory Approvals
  • 9.4. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, FY2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)
  • 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Becton Dickinson India Private Limited
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products & Services
    • 13.1.4. Financials (As reported)
    • 13.1.5. Key Market Focus & Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. Agilent Technologies India Private Limited
  • 13.3. Illumina Inc.
  • 13.4. Thermo Fisher Scientific Inc.
  • 13.5. Roche Products India Private Limited
  • 13.6. Bio-Rad Laboratories India Private Limited
  • 13.7. Merck Life Science Private Limited
  • 13.8. Wipro GE Healthcare Private Limited
  • 13.9. Bruker India Scientific Private Limited
  • 13.10. Qiagen India Private Limited

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14. Strategic Recommendations

15. About Us & Disclaimer

List of Tables

  • Table 01: Import Analysis, FY2017-FY2023
  • Table 02: Export Analysis, FY2017-FY2023
  • Table 03: India Life Science Tools Market - Competition Matrix of Market Leaders, FY2023

List of Figures

  • Figure 01: COVID-19 Market Impact (By %)
  • Figure 02: India Life Science Tools Market, By Value, In USD Billion, FY2017-2031F
  • Figure 03: India Life Science Tools Market, By Volume, In Units, FY2017-2031F
  • Figure 04: India Life Science Tools Market Share, By Type, By Value Share, In %, FY2017-2031F
  • Figure 05: India Life Science Tools Market Share, By Technology, By Value Share, In %, FY2017-2031F
  • Figure 06: India Life Science Tools Market Share, By Product, By Value Share, In %, FY2017-2031F
  • Figure 07: India Life Science Tools Market Share, By End-user, By Value Share, In %, FY2017-2031F
  • Figure 08: India Life Science Tools Market Share, By Region, By Value Share, In %, FY2017-2031F
  • Figure 09: India Life Science Tools Market Share, By Company Market Share (%), FY2023
  • Figure 10: By Type Map-Market Size (USD Billion, FY2023) & Growth Rate (%, FY2024E-2031F)
  • Figure 11: By Technology Map-Market Size (USD Billion, FY2023) & Growth Rate (%, FY2024E-2031F)
  • Figure 12: By Product Map-Market Size (USD Billion, FY2023) & Growth Rate (%, FY2024E-2031F)
  • Figure 13: By End-user Map-Market Size (USD Billion, FY2023) & Growth Rate (%, FY2024E-2031F)
  • Figure 14: By Region Map-Market Size (USD Billion, FY2023) & Growth Rate (%, FY2024E-2031F)
  • Figure 15: Number of Patent Filings, FY2017-2021
  • Figure 16: India Life Sciences Patent Filings, FY2017-2021
  • Figure 17: Market Revenue, in USD Million, FY2022